In the US, the Rocky Mountain Poison and Drug Center protocol treats repeated supratherapeutic ingestion patients with 12 h of NAC, with treatment only being continued if ALT/AST is rising or the paracetamol concentration is elevated [Citation107]

Water(Aqua), C13-15 Alkane, **Niacinamide, Butylene Glycol, Caprylic/Capric Triglyceride, Tranexamic Acid, Glycerin, **Arbutin, 1,2-Hexanediol, **Glutathione, Borago Officinalis Seed Oil, Glycine Soja (Soybean) Seed Extract, **Alpha-Arbutin, **Acetyl Glucosamine, Panthenol, Xanthan Gum, Potassium Cetyl Phosphate, Allantoin, Ethylhexylglycerin, Melia Azadirachta Flower Extract, Disodium EDTA, Ocimum Sanctum Leaf Extract, Polyglutamic Acid, Melia Azadirachta Leaf Extract, Curcuma Longa (Turmeric) Root Extract, Corallina Officinalis Extract, Squalane, Sodium Hyaluronate, **Kojic Acid, Ascorbic Acid, Centella Asiatica Extract, Tocopherol, Citrus Limon (Lemon) Fruit Extract, Hydroxypropyltrimonium Hyaluronate, Hydrolyzed Hyaluronic Acid, Sodium Acetylated Hyaluronate,Hyaluronic Acid, Hydrolyzed Sodium Hyaluronate, Sodium Hyaluronate Crosspolymer, Polyglyceryl-10 Laurate, Potassium Hyaluronate, Phosphatidylcholine, Tocopheryl AcetateWater(Aqua), C13-15 Alkane, **Niacinamide, Butylene Glycol, Caprylic/Capric Triglyceride, Tranexamic Acid, Glycerin, **Arbutin, 1,2-Hexanediol, **Glutathione, Borago Officinalis Seed Oil, Glycine Soja (Soybean) Seed Extract, **Alpha-Arbutin, **Acetyl Glucosamine, Panthenol, Xanthan Gum, Potassium Cetyl Phosphate, Allantoin, Ethylhexylglycerin, Melia Azadirachta Flower Extract, Disodium EDTA, Ocimum Sanctum Leaf Extract, Polyglutamic Acid, Melia Azadirachta Leaf Extract, Curcuma Longa (Turmeric) Root Extract, Corallina Officinalis Extract, Squalane, Sodium Hyaluronate, **Kojic Acid, Ascorbic Acid, Centella Asiatica Extract, Tocopherol, Citrus Limon (Lemon) Fruit Extract, Hydroxypropyltrimonium Hyaluronate, Hydrolyzed Hyaluronic Acid, Sodium Acetylated Hyaluronate,Hyaluronic Acid, Hydrolyzed Sodium Hyaluronate, Sodium Hyaluronate Crosspolymer, Polyglyceryl-10 Laurate, Potassium Hyaluronate, Phosphatidylcholine, Tocopheryl Acetate

Has the combination been studied in humans
3 In the past, liver transplantation had been the only therapeutic option for LAL-D because liver fibrosis progression was refractory to statin therapy
CPT II deficiency The adult CPT II clinical phenotype is somewhat benign and requires additional external triggers such as high-intensity exercise before the predominantly myopathic symptoms are elicited
Compound heterozygous ATP7B mutation D